https://www.nice.org.uk/guidance/ng109/chapter/Other-considerations
Other considerations | Urinary tract infection (lower): antimicrobial prescribing | Guidance | NICE
This guideline sets out an antimicrobial prescribing strategy for lower urinary tract infection (also called cystitis) in children, young people and adults who...
urinary tract infectionother considerationsprescribing guidancelowerantimicrobial
https://www.nice.org.uk/guidance/ng79?UNLID=870160392026422154523
Overview | Sinusitis (acute): antimicrobial prescribing | Guidance | NICE
This guideline sets out an antimicrobial prescribing strategy for acute sinusitis. It aims to limit antibiotic use and reduce antimicrobial resistance. Acute...
prescribing guidanceoverviewsinusitisacuteantimicrobial
https://www.nice.org.uk/guidance/ng199/evidence
Evidence | Clostridioides difficile infection: antimicrobial prescribing | Guidance | NICE
This guideline sets out an antimicrobial prescribing strategy for managing Clostridioides difficile infection in adults, young people and children aged 72...
clostridioides difficileprescribing guidanceevidenceinfectionantimicrobial
https://www.nice.org.uk/guidance/ng109/evidence
Evidence | Urinary tract infection (lower): antimicrobial prescribing | Guidance | NICE
This guideline sets out an antimicrobial prescribing strategy for lower urinary tract infection (also called cystitis) in children, young people and adults who...
urinary tract infectionprescribing guidanceevidencelowerantimicrobial
https://www.ama-assn.org/public-health/behavioral-health/new-guidance-who-can-benefit-naloxone-co-prescribing
New guidance: Who can benefit from naloxone co-prescribing | American Medical Association
The opioid-overdose antidote naloxone saves lives. Co-prescribing it to patients at risk for overdose provides a tangible and timely option for care.
who can benefitnew guidance